Revision 1

#12879Store at -20C

1 Kit

(7 x 20 microliters)

Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Product Includes Product # Quantity Mol. Wt Isotype/Source
Phospho-IRS-1 (Ser302) (34C7) Rabbit mAb 2491 20 µl 180 kDa Rabbit IgG
Phospho-IRS-1 (Ser307) Antibody 2381 20 µl 180 kDa Rabbit 
Phospho-IRS-1 (Ser318) (D51C3) Rabbit mAb 5610 20 µl 180 kDa Rabbit IgG
Phospho-IRS-1 (Ser612) (C15H5) Rabbit mAb 3203 20 µl 180 kDa Rabbit IgG
Phospho-IRS-1 (Ser636/639) Antibody 2388 20 µl 180 kDa Rabbit 
Phospho-IRS-1 (Ser1101) Antibody 2385 20 µl 180 kDa Rabbit 
IRS-1 (D23G12) Rabbit mAb 3407 20 µl 180 kDa Rabbit IgG
Anti-rabbit IgG, HRP-linked Antibody 7074 100 µl Goat 

Please visit cellsignal.com for individual component applications, species cross-reactivity, dilutions, protocols, and additional product information.

Description

The IRS-1 Inhibition Antibody Sampler Kit provides an economical means to evaluate insulin signaling negative feedback loops via phosphorylation of various IRS-1 serine residues. The kit includes enough antibody to perform two western blot experiments with each primary antibody.

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Background

Insulin receptor substrate 1 (IRS-1) is one of the major substrates of the insulin receptor kinase (1). IRS-1 contains multiple tyrosine phosphorylation motifs that serve as docking sites for SH2-domain containing proteins that mediate the metabolic and growth-promoting functions of insulin (2-4). IRS-1 also contains over 30 potential serine/threonine phosphorylation sites, many of which are related to negative feedback loops activated during insulin signaling. Ser302 (human Ser307) of IRS-1 is regulated by FOX01 (5), IKKγ, and MYO1C (6). Ser307 (human Ser312) of IRS-1 is phosphorylated by JNK (7) and IKK (8). PKC phosphorylates mouse IRS-1 at Ser318 (human Ser323) by insulin receptor activation or by other stimulation such as TPA, IL-6, and retinoic acid treatment (9-12). The PKC and mTOR pathways mediate phosphorylation of IRS-1 at Ser612 (human Ser616) and Ser632/635 (human Ser636/639), respectively (13,14). Phosphorylation of IRS-1 at Ser1097 (human Ser1101) is mediated by PKCθ and results in an inhibition of insulin signaling in the cell, suggesting a potential mechanism for insulin resistance in some models of obesity (15).

  1. Sun, X.J. et al. (1991) Nature 352, 73-7.
  2. Sun, X.J. et al. (1992) J Biol Chem 267, 22662-72.
  3. Myers, M.G. et al. (1993) Endocrinology 132, 1421-30.
  4. Wang, L.M. et al. (1993) Science 261, 1591-4.
  5. Cao, Y. et al. (2006) J Biol Chem 281, 40242-51.
  6. Nakamori, Y. et al. (2006) J Cell Biol 173, 665-71.
  7. Rui, L. et al. (2001) J Clin Invest 107, 181-9.
  8. Gao, Z. et al. (2002) J Biol Chem 277, 48115-21.
  9. Greene, M.W. et al. (2004) Biochem J 378, 105-16.
  10. Weigert, C. et al. (2006) J Biol Chem 281, 7060-7.
  11. del Rincón, S.V. et al. (2004) Oncogene 23, 9269-79.
  12. Moeschel, K. et al. (2004) J Biol Chem 279, 25157-63.
  13. Ozes, O.N. et al. (2001) Proc Natl Acad Sci U S A 98, 4640-5.
  14. De Fea, K. and Roth, R.A. (1997) Biochemistry 36, 12939-47.
  15. Li, Y. et al. (2004) J Biol Chem 279, 45304-7.

Background References

    Trademarks and Patents

    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    U.S. Patent No. 7,429,487, foreign equivalents, and child patents deriving therefrom.
    All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

    Limited Uses

    Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.

    Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.